Literature DB >> 10818002

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

A Oliver1, R Cantón, P Campo, F Baquero, J Blázquez.   

Abstract

The lungs of cystic fibrosis (CF) patients are chronically infected for years by one or a few lineages of Pseudomonas aeruginosa. These bacterial populations adapt to the highly compartmentalized and anatomically deteriorating lung environment of CF patients, as well as to the challenges of the immune defenses and antibiotic therapy. These selective conditions are precisely those that recent theoretical studies predict for the evolution of mechanisms that augment the rate of variation. Determination of spontaneous mutation rates in 128 P. aeruginosa isolates from 30 CF patients revealed that 36% of the patients were colonized by a hypermutable (mutator) strain that persisted for years in most patients. Mutator strains were not found in 75 non-CF patients acutely infected with P. aeruginosa. This investigation also reveals a link between high mutation rates in vivo and the evolution of antibiotic resistance.

Entities:  

Mesh:

Year:  2000        PMID: 10818002     DOI: 10.1126/science.288.5469.1251

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  528 in total

1.  Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.

Authors:  B Björkholm; M Sjölund; P G Falk; O G Berg; L Engstrand; D I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 2.  Stress-induced evolution and the biosafety of genetically modified microorganisms released into the environment.

Authors:  V V Velkov
Journal:  J Biosci       Date:  2001-12       Impact factor: 1.826

3.  Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations.

Authors:  María-Cristina Negri; María-Isabel Morosini; María-Rosario Baquero; Rosa del Campo; Jesús Blázquez; Fernando Baquero
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Regulation of mutY and nature of mutator mutations in Escherichia coli populations under nutrient limitation.

Authors:  Lucinda Notley-McRobb; Rachel Pinto; Shona Seeto; Thomas Ferenci
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

5.  Mutator dynamics in fluctuating environments.

Authors:  J M J Travis; E R Travis
Journal:  Proc Biol Sci       Date:  2002-03-22       Impact factor: 5.349

6.  Mutator clones of Neisseria meningitidis in epidemic serogroup A disease.

Authors:  Anthony R Richardson; Zhong Yu; Tanja Popovic; Igor Stojiljkovic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

7.  Over-representation of repeats in stress response genes: a strategy to increase versatility under stressful conditions?

Authors:  Eduardo P C Rocha; Ivan Matic; François Taddei
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

8.  Mutator bacteria as a risk factor in treatment of infectious diseases.

Authors:  Antoine Giraud; Ivan Matic; Miroslav Radman; Michel Fons; François Taddei
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

9.  Use of mutator strains for characterization of novel antimicrobial agents.

Authors:  A J O'Neill; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 10.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.